Stay updated on Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial
Sign up to get notified when there's something new on the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page.

Latest updates to the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page
- Check6 days agoChange DetectedThe study page adds a recruitment status note ('No longer looking for participants') and new help links (How to Read a Study Record, Common Questions, How to Join a Study), while updating the Intervention/Treatment label from 'Intervention / Treatment' to 'Intervention/Treatment' and including a site revision marker ('Revision: v3.6.0').SummaryDifference0.4%

- Check13 days agoChange DetectedRevision: v3.5.5 replaces the previous v3.5.4 on the page, signaling a new version of the page's content or template. This update does not change the study details or eligibility information.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a platform/template update for the page. This update affects the underlying framework but does not modify the displayed study content.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a technical site update rather than an update to the trial information shown.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This change does not affect the study data or content presented.SummaryDifference0.1%

- Check92 days agoChange DetectedSite version updated from v3.4.3 to v3.5.0. No study content or user-facing information appears to have changed.SummaryDifference0.1%

Stay in the know with updates to Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page.